Follow Invezz on Telegram , Twitter , and Google News for instant updates > Novavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the company’s fiscal Q1 2024 earnings report but more significantly, by a crucial multi-billion dollar deal with French pharmaceutical giant Sanofi SA. Are you looking for signals & alerts from pro-traders? Sign-up to Invezz Signals™ for FREE. Takes 2 mins. Despite reporting a first-quarter loss per share of $1.05, wider than the$0.92 anticipa ...